The aim of the present work is to investigate the involvement of B2R in the mechanism of action of NGF in vitro in cortical primary cultures and in hippocampal slices, and in vivo in AD transgenic mice chronically treated with NGF. The gene discussed is BDKRB2; the disease is Alzheimer disease.